<?xml version="1.0" encoding="UTF-8"?>
<document id="29658567">
	<sentence id="s1" text="The expression of hepatocyte cell adhesion molecule (HepaCAM), a novel tumor suppressor, is frequently downregulated or lost in PCa.">
		<entity id="s1.e1" charOffset="53-60"
			type="GENE" text="HepaCAM" ontology_id="220296"/>
		<entity id="s1.e2" charOffset="71-76"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Furthermore, the overexpression of HepaCAM induced by transfection with a HepaCAM overexpression vector (Ad-HepaCAM) exerted antitumor effects by decreasing the proliferation, and suppressing the invasion and migration of bicalutamide-resistant (Bica-R) cells and enzalutamide-resistant (Enza-R) cells.">
		<entity id="s2.e1" charOffset="35-42"
			type="GENE" text="HepaCAM" ontology_id="220296"/>
		<entity id="s2.e2" charOffset="129-134"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Importantly, we found that the antitumor effects of HepaCAM on the resistant cells were associated with the downregulation of Notch signaling.">
		<entity id="s3.e1" charOffset="35-40"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="52-59"
			type="GENE" text="HepaCAM" ontology_id="220296"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="In this study, we found that the activities of Notch signaling were elevated, while HepaCAM expression was decreased in CRPC tissues compared with matched primary prostate cancer (PPC) tissues.">
		<entity id="s4.e1" charOffset="84-91"
			type="GENE" text="HepaCAM" ontology_id="220296"/>
		<entity id="s4.e2" charOffset="172-178"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
</document>
